Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8EZ5 | Q8DJI1 | RT XFEL structure of the two-flash state of Photosystem II (2F, S3-rich) at 2.09 Angstrom resolution | |
| 8EZ5 | Q8DHJ2 | RT XFEL structure of the two-flash state of Photosystem II (2F, S3-rich) at 2.09 Angstrom resolution | |
| 8EZ7 | Q8AZ87 | Structure of 1F04 Fab in complex with A/Moscow/10/1999 (H3N2) influenza virus neuraminidase | |
| 8EZ7 | 8EZ7 | Structure of 1F04 Fab in complex with A/Moscow/10/1999 (H3N2) influenza virus neuraminidase | |
| 8EZ8 | Q8AZ87 | Structure of 3C08 Fab in complex with A/Moscow/10/1999 (H3N2) influenza virus neuraminidase | |
| 8EZ8 | 8EZ8 | Structure of 3C08 Fab in complex with A/Moscow/10/1999 (H3N2) influenza virus neuraminidase | |
| 8EZL | P13829 | Pfs25 in complex with transmission-reducing antibody AS01-50 | |
| 8EZL | 8EZL | Pfs25 in complex with transmission-reducing antibody AS01-50 | |
| 8EZM | P13829 | Pfs25 in complex with transmission-reducing antibody AS01-63 | |
| 8EZM | 8EZM | Pfs25 in complex with transmission-reducing antibody AS01-63 | |
| 8F0G | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3 | |
| 8F0G | 8F0G | Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3 | |
| 8F0H | 8F0H | Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs 1H2 and 2A10) | |
| 8F0H | P0DTC2 | Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs 1H2 and 2A10) | |
| 8F0I | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22 | |
| 8F0I | 8F0I | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22 | |
| 8F0J | P63092 | Calcitonin Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
| 8F0J | P62873 | Calcitonin Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
| 8F0J | P59768 | Calcitonin Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
| 8F0J | 8F0J | Calcitonin Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
| 8F0J | P30988 | Calcitonin Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
| 8F0K | P63092 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 | |
| 8F0K | P62873 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 | |
| 8F0K | O60896 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 | |
| 8F0K | P59768 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 | |
| 8F0K | 8F0K | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 | |
| 8F0K | P30988 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 | |
| 8F0M | P01116-2 | Monobody 12D5 bound to KRAS(G12D) | |
| 8F0M | 8F0M | Monobody 12D5 bound to KRAS(G12D) | |
| 8F0O | P42260 | cryo-EM structure of homomeric kainate receptor GluK2 in resting (apo) state | |
| 8F0P | D0E0C2 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the hybrid inhibitor GNE-1305 | |
| 8F0P | Q15858 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the hybrid inhibitor GNE-1305 | |
| 8F0Q | D0E0C2 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the acylsulfonamide inhibitor GDC-0310 | |
| 8F0Q | Q15858 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the acylsulfonamide inhibitor GDC-0310 | |
| 8F0R | D0E0C2 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the arylsulfonamide inhibitor GNE-3565 | |
| 8F0R | Q15858 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the arylsulfonamide inhibitor GNE-3565 | |
| 8F0S | D0E0C2 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the hybrid inhibitor GNE-9296 | |
| 8F0S | Q15858 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the hybrid inhibitor GNE-9296 | |
| 8F0S | P49126 | Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the hybrid inhibitor GNE-9296 | |
| 8F0V | Q6SVB5 | Lipocalin-like Milk protein-2 - E38A mutant | |
| 8F0Y | Q6SVB6 | Lipocalin-like Milk protein-1 | |
| 8F2A | P63092 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 8F2A | P62873 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 8F2A | O60896 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 8F2A | P59768 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 8F2A | 8F2A | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 8F2A | P30988 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 8F2B | P63092 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
| 8F2B | P62873 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
| 8F2B | O60896 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 |
